Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

Journal of Clinical Investigation

Volumn 103, Issue 9, 1999, Pages 1231-1236

  Isner, Jeffrey M ^a,b   Asahara, Takayuki ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; NITRIC OXIDE SYNTHASE; SCATTER FACTOR;

ANGIOGENESIS; GENE TRANSFER; HEART MUSCLE ISCHEMIA; HUMAN; LIMB ISCHEMIA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; REVIEW; TUMOR BLOOD FLOW;

EID: 0033134604     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6889     Document Type: Review

References (28)

1. Folkman, J. 1971. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1182-1186.
2. Takeshita, S., et al. 1994. Therapeutic angiogenesis: a single intra-arterial bolus of vascular entdothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J. Clin. Invest. 93:662-670.
3. Ware, J.A., and Simons, M. 1997. Angiogenesis in ischemic heart disease. Nat. Med. 3:158-164.
4. Arras, M., et al. 1998. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101:40-50.
5. Mack, C.A., et al. 1998. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and Function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg. 115:168-176.
6. Losordo, D.W., et al. 1994, Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo: evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation. 89:785-792.
7. Murohara, T., et al. 1998. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101:2567-2578.
8. Wang, H., and Keiser, J.A. 1998. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of fit-1. Circ. Res. 83:832-840.
9. 165. Lancet. 348:370-374.
10. 165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 97:1114-1123.
11. 165 as sole therapy for myocardial ischemia. Circulation. 98:2800-2804.
12. Schumacher, B., Pecher, P., von Specht, B.U., and Stegmann, H. 1998. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation. 97:645-650.
13. Namiki, A., et al. 1995. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem. 270:31189-31195.
14. Shen, B-Q., et al. 1998. Homologous upregulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J. Biol. Chem. 273:29979-29985.
15. Fujio, Y., and Walsh, K. 1999. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem. In press.
16. Brogi, E., et al. 1996. Hypoxia-induced paracrine regulation of VEGF receptor expression. J. Clin. Invest. 97:469-476.
17. Springer, M.L., Chen, A.S., Kraft, P.E., Bednarski, M., and Blau, H.M. 1998. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol. Cell. 2:549-558.
18. Isner, J. M., et al. 1998. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J. Vasc. Surg. 28:964-975.
19. Rivard, A., et al. 3999. Age-dependent impairment of angiogenesis. Circulation. 99:111-120.
20. Rivard, A., et al. 1999. Rescue of diabetes related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am. J. Pathol. 154:355-364.
21. -/- mice. Circulation. In press.
22. Stohlawetz, P., et al. 1996. The effect of age on the transendothelial migration of human T lymphocytes. Scand. J. Immunol. 44:530-534.
23. Asahara, T., et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:965-967.
24. Takahashi, T., et al. 1999. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5:434-438.
25. Solovey, A., et al. 1997. Circulating activated endothelial cells in sickle cell anemia. N. Engl. J. Med. 337:1582-1590.
26. Risau, W., et al. 1988. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development. 102:471-478.
27. Shi, Q., et al. 1998. Evidence for circulating bone marrow-derived endothelial cells. Blood. 92:362-367.
28. Hatzopoulos, A.K., Folkman, J., Vasile, E., Eiselen, G.K., and Rosenberg, R.D. 1998. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development. 125:1457-1468.